Guardant Health Stock News & Updates
[WKN: A2N5RY | Symbol: GH]
Guardant Health: High Revenue Dynamics in an Underserved Market
The business model in focus: Guardant Health specializes in precision oncology and develops innovative...
Analysts' Top 5 Price Targets of June 08, 26
BrightSpring Health [US10950A1060] Goldman Sachs initiates coverage with "Buy" and a price target of...
Guardant Health sees stock jump after FDA approval for Guardant360 Liquid CDx
FDA approvals for Guardant360 tests provide new momentum in May. The release of Guardant360 Liquid...
Analysts' Top 5 Price Targets of April 1, 2026
CTS Eventim [DE0005470306] JPMorgan confirms Overweight rating - but reduces the price target from...
Analysts' Top 5 Price Targets of February 23, 2026
Guardant Health [US40131M1099] Leerink Partners reaffirms Outperform rating and raises the price target...
Megamarket Liquid Biopsy: Guardant Health Emerges as a Winner Stock!
I've been discussing Guardant Health extensively in the Tenbagger Forum since early 2020. Back then,...
Analysts' Top 5 Price Targets of December 16, 2025
KalVista Pharmaceuticals [US4834971032] Bank of America confirms Buy rating and adjusts the...
Tracking the Pivotal Point of Guardant Health (GH): 39% Revenue Growth in Q3 and Increased Annual Forecast in Oncology!
Guardant Health's stock saw a significant rally on October 30, 2025, after the company announced its...
Guardant Health: Four Reasons for a Successful Breakout
In the current market environment, I am increasingly focusing on growth stocks that demonstrate relative...
Guardant Health - Rising Patient Numbers Provide Strong Prospects for Diagnostic Specialist
Business driver: Guardant Health (GH) specializes in the development and marketing of blood tests for...
Analysts' Top 5 Price Targets of September 22, 2025
Super Group [GG00BMG42V42] Canaccord confirms Buy rating and adjusts the price target from $17...